UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By BOPA Education & Training Subcommittee on 9th March 2026

Webinar Cancelled: AI Implementation: Taking a chemotherapy risk prediction AI model from research into industry and practice

Dear BOPA members Due to unforeseen circumstances tomorrow’s webinar AI Implementation: Taking a chemotherapy risk prediction AI model from research into industry and practice (10th March 2026) had to be cancelled. Will…

Read article
By BOPA Digital SACT Verification Passport Team on 9th March 2026

BOPA SACT Passport: Reminder to ALL Super-managers, Managers and Assessors

Dear BOPA Members and Digital SACT Verification Passport Users This is a reminder to all super-managers, managers and assessors of the BOPA SACT Passport to: – Ensure all staff within your Passport…

Read article
By BOPA Research Subcommittee on 9th March 2026

Abstract Submission for #BOPA2026 opens 30th March 2026

Abstract Submission for the 29th Annual BOPA Conference 2026 opens on 30th March 2026     Delegates are invited to present results of their clinical and technical work as a…

Read article
By BOPA Committee on 7th March 2026

UK BMT Pharmacists Group Hybrid Educational Meeting – Friday 17th April 2026

Dear colleagues, Further to the save the date for this event, previously circulated, please find attached the agenda for the UK BMT Pharmacists Group Hybrid Educational Meeting, taking place on…

Read article